Nuvectis Pharma, Inc. (NVCT) Tops Q1 EPS by 15c

Nuvectis Pharma, Inc. (NASDAQ: NVCT) reported Q1 EPS of ($0.25), $0.15 better than the analyst estimate of ($0.40).

For earnings history and earnings-related data on Nuvectis Pharma, Inc. (NVCT) click here.

You May Also Be Interested In

• NIO Inc. (NIO) Tops Q2 EPS by 33c; offers guidance
• Oracle (ORCL) PT Lowered to $290 at Jefferies
• Morgan Stanley Downgrades Smith & Nephew PLC. (SN:LN) (SNN) to Equalweight